2
The drug continues do dominate the market for prescription weight-loss drugs in the U.S.
Lilly raises outlook for third time this year as Zepbound sales soar.
At Srivax, we believe in delivering fast, accurate, and relevant news to empower, inform, and engage our readers across the globe. We are an independent digital news platform built for the modern world — where information moves fast, and truth matters.
